Invitae Announces Selection of Finance Executive Robert Dickey as Interim CFO

– Christine Gorjanc resumes role as Chair of the Audit Committee of the Board of Directors for Invitae – SAN FRANCISCO, Aug. 14, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Robert Dickey has been named its interim chief financial…

Click here to view original post